TYPE-1 DIABETES-MELLITUS AND HOMOCYST(E)INE

被引:0
|
作者
ROBILLON, JF
CANIVET, B
CANDITO, M
SADOUL, JL
JULLIEN, D
MORAND, P
CHAMBON, P
FREYCHET, P
机构
[1] CHU NICE,HOP LOUIS PASTEUR,DEPT BIOCHEM,F-06002 NICE 1,FRANCE
[2] CHU NICE,HOP LOUIS PASTEUR,DEPT CARDIOVASC DIS,F-06002 NICE 1,FRANCE
来源
DIABETES & METABOLISM | 1994年 / 20卷 / 05期
关键词
HOMOCYST(E)INE; TYPE 1 DIABETES (IDDM); ATHEROSCLEROSIS; VASCULAR RISK FACTOR;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
High Homocyst(e)ine levels (H) have been recently recognized as a risk factor for atherosclerosis. Patients with Diabetes Mellitus (DM) are prone to atherosclerosis. Therefore, this study was designed to search for the effect of DM on H and their relationship. Forty-one Type 1 diabetic subjects (DS, age 34.8 +/- 12 yr, DM duration : 10.7 +/- 11.1 yr) were compared to 40 age-matched control subjects (CS, age 34.2 +/- 9.1 yr). H (measured by ion-exchange chromatography, units : mu mol/l) and several parameters (creatininaemia; triglycerides; total, HDL, LDL cholesterol; Lp(a); HbA1c; vitamins B9 and B12) were determined after an overnight fast. H were significantly (p = 0.0001) lower in DS (6.8 +/- 2.2) than in CS (9.5 +/- 2.9). This difference was still apparent in male and female subgroups compared to matched CS (p = 0.003 for each). No correlation was found between H and : lipids, vitamins, renal or retinal status. But H seemed to increase with age, especially in women (p = 0.03; r = 0.32). While there is, at this time, no explanation for the lower H observed in DS, it appears that H cannot directly account for accelerated atherosclerosis in DM. Nevertheless, it remains to be established if high, or even normal, H could identify a subgroup of DS at higher risk of precocious and severe atherosclerosis.
引用
收藏
页码:494 / 496
页数:3
相关论文
共 50 条
  • [41] EPIDEMIOLOGY OF DIABETES-MELLITUS TYPE-1 - A PATHWAY TO THE PREVENTION OF THE DISEASE
    ARNO, AG
    MEDICINA CLINICA, 1990, 95 (05): : 178 - 182
  • [42] FALSE NORMAL HEMOGLOBIN ALC IN TYPE-1 DIABETES-MELLITUS
    BARBER, AR
    PRICE, DA
    MIMS, RB
    CLINICAL RESEARCH, 1994, 42 (01): : A103 - A103
  • [43] GLOMERULAR HYPERFILTRATION AND URINARY PROSTAGLANDINS IN TYPE-1 DIABETES-MELLITUS
    VIBERTI, GC
    BENIGNI, A
    BOGNETTI, E
    REMUZZI, G
    WISEMAN, MJ
    DIABETIC MEDICINE, 1989, 6 (03) : 219 - 223
  • [44] SERUM SODIUM RESPONSE TO HYPERGLYCEMIA IN TYPE-1 DIABETES-MELLITUS
    AW, TC
    LYEN, KR
    KIECHLE, FL
    CLINICAL RESEARCH, 1983, 31 (02): : A380 - A380
  • [45] NATURAL-HISTORY OF NEPHROPATHY IN TYPE-1 DIABETES-MELLITUS
    ESMATJES, E
    GUTIERREZ, A
    GODAY, A
    NOVIALS, A
    RICART, MJ
    GONZALEZ, MT
    GARCIA, M
    RIOS, M
    FIGUEROLA, D
    MEDICINA CLINICA, 1988, 90 (02): : 47 - 49
  • [46] ERYTHROCYTE LACTATE-DEHYDROGENASE IN TYPE-1 DIABETES-MELLITUS
    RIZVI, SI
    NATIONAL ACADEMY SCIENCE LETTERS-INDIA, 1995, 18 (3-4): : 81 - 83
  • [47] LIMITATION OF ARTICULAR MOBILITY IN A PATIENT WITH TYPE-1 DIABETES-MELLITUS
    ALFONSO, GO
    MANTECA, JM
    SALA, AS
    MARTIN, AL
    SALA, MF
    MEDICINA CLINICA, 1982, 79 (05): : 240 - 241
  • [48] ERYTHROCYTE-MEMBRANE FLUIDITY IN TYPE-1 DIABETES-MELLITUS
    HILL, MA
    COURT, JM
    PATHOLOGY, 1983, 15 (04) : 449 - 451
  • [49] DETECTION OF NOCTURNAL HYPOGLYCEMIA IN CHILDREN WITH TYPE-1 DIABETES-MELLITUS
    VETTER, U
    WINKLER, G
    HEINZE, E
    TELLER, W
    PEDIATRIC RESEARCH, 1981, 15 (12) : 1572 - 1572
  • [50] MICROVASCULAR EFFECTS OF RAMIPRIL IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS
    HAAK, E
    HAAK, T
    KUSTERER, K
    RESCHKE, B
    FAUST, H
    USADEL, KH
    DIABETOLOGIA, 1995, 38 : A49 - A49